Hearing a cancer diagnosis is like a sentence dropped suddenly into the middle of your life. The moment a doctor says the words “squamous cell carcinoma”, the first thing most people think of is not a medical question at all, but fear, uncertainty and the feeling of “what happens now?”. These feelings are completely natural, and almost everyone who receives a diagnosis goes through a similar period. But there is an important fact to know right from the start: squamous cell carcinoma is one of the best understood and most thoroughly researched cancers in modern oncology, and when it is caught at an early stage in particular, treatment success rates are very high.
This guide has been written to help people diagnosed with squamous cell carcinoma, and their families, understand the process more clearly. It explains step by step what the disease is, which organs it affects, how it is staged, which treatments are used, what to expect during treatment and how follow-up is organised afterwards. The aim is to help you ask the right questions in your conversations with your doctor and manage the process with confidence.
What Is Squamous Cell Carcinoma?
Squamous cell carcinoma, also known as squamous cell cancer or epidermoid carcinoma, takes its name from the type of cell it arises from. Squamous cells (flat epithelial cells) are thin, flat cells that cover many surfaces of the body. They are found in the outermost layer of the skin, on the inner lining of the mouth and throat, in the oesophagus, in the windpipe and the large airways of the lungs, in the cervix and in the anal region.
Cancer develops when these cells begin to multiply uncontrollably as a result of accumulated damage to their DNA. Under normal conditions, cells have a defined life cycle: they age, complete their task and die in a programmed way. In squamous cell carcinoma this balance is disrupted; instead of dying, the cells keep multiplying and form a mass. Over time this mass can grow into surrounding tissues and spread to distant areas through the lymphatic vessels or the bloodstream.
The most important point is that squamous cell carcinoma is not a single disease. Although it always arises from the same cell type, its behaviour, treatment approach and course differ markedly depending on the organ in which it develops. A squamous cell carcinoma of the skin and a squamous cell carcinoma of the lung share a name but require completely different treatment plans. Knowing which organ is named in your diagnostic report is therefore the first step towards understanding the process.
Where Does Squamous Cell Carcinoma Occur?
Squamous Cell Carcinoma of the Skin
Cutaneous squamous cell carcinoma is the most common form worldwide and the second most common skin cancer after basal cell carcinoma. It usually appears on the areas most exposed to the sun: the face, ears, lips, scalp, neck, backs of the hands and forearms. Most cases are detected early and can be completely cured by surgery alone. The great majority of cutaneous squamous cell carcinomas do not spread; however, if neglected or if they have certain high-risk features, they can invade deeper tissues and spread to the lymph nodes.
Head and Neck Squamous Cell Carcinoma
Most cancers arising from the inside of the mouth, the tongue, the lips, the tonsils, the pharynx, the larynx and the nasal and sinus region are squamous cell carcinomas. Two different patient profiles stand out in this group. The first is the classic type, associated with long-term smoking and alcohol use. The second consists of tumours linked to HPV (human papillomavirus), particularly those located in the tonsils and the base of the tongue. HPV-related tumours tend to occur at a younger age and respond markedly better to treatment; for this reason they are classified as a separate category in current staging systems.
Squamous Cell Carcinoma of the Lung
Squamous cell carcinoma of the lung is one of the main subtypes of non-small cell lung cancer. It usually develops in the centre of the lung, close to the large airways, and is strongly associated with smoking. Because of this location, symptoms such as coughing, blood in the sputum and recurrent lung infections may appear early. Since immunotherapy drugs were introduced over the past decade, life expectancy in this group has improved markedly.
Other Locations
The oesophagus, the cervix, the anal canal, the vagina, the penis and the bladder are also sites where squamous cell carcinoma can occur. HPV infection is the main cause of cervical and anal cancers, and vaccination offers protection in both areas. Squamous cell carcinoma of the oesophagus, on the other hand, has been linked to drinking very hot beverages, smoking, alcohol and dietary habits.
Why Does Squamous Cell Carcinoma Develop? Risk Factors
Looking for a single cause of cancer is usually not the right approach. Squamous cell carcinoma is generally the result of cellular damage accumulated over many years. Nevertheless, certain factors are well known to increase the risk:
- Ultraviolet (UV) radiation: the most important cause of cutaneous squamous cell carcinoma. Sun exposure spread over many years, severe sunburns in childhood and the use of sunbeds increase the risk considerably.
- Smoking and tobacco products: the strongest risk factor for head and neck, lung and oesophageal squamous cell carcinomas. Besides cigarettes, pipes, cigars, water pipes and chewing tobacco also carry a risk.
- Alcohol use: multiplies the risk, especially when combined with smoking.
- HPV infection: the main cause of cervical and anal cancers and of some head and neck tumours.
- Immunosuppression: the risk rises considerably in people taking immunosuppressive drugs after an organ transplant, in those on long-term cortisone treatment and in conditions such as HIV. In this group the disease may behave more aggressively.
- Chronic wounds and inflammation: the cancer can develop in long-standing non-healing wounds, old burn scars, fistula sites or areas of chronic skin disease.
- Precursor lesions: lesions such as actinic keratosis on the skin or leukoplakia in the mouth can turn into cancer over time.
- Older age, fair skin and a previous skin cancer: these factors apply particularly to the skin type.
- Radiation and chemical exposure: previous radiotherapy, arsenic exposure or certain occupational chemical exposures can increase the risk.
Squamous cell carcinoma can also develop in people who have none of these risk factors. For this reason, no one who receives the diagnosis needs to blame themselves or get stuck on the question “what did I do to cause this?”. Directing your energy towards the treatment rather than questioning the past will be far more helpful.
What Are the Symptoms?
Symptoms vary depending on where the tumour is located. Squamous cell carcinoma of the skin usually appears as a hardened, crusting, rough-surfaced bump or as a sore that does not heal. It may bleed from time to time, shed its crust and crust over again. Any skin lesion that has not healed for more than a few weeks should be assessed by a dermatologist.
In the head and neck region, the main symptoms are a sore in the mouth that does not heal, a feeling of something stuck in the throat, difficulty swallowing, hoarseness, pain radiating to the ear, a lump in the neck and unexplained weight loss. Hoarseness or a mouth ulcer that lasts longer than three weeks should always be evaluated.
In the lung, a persistent cough, blood in the sputum, shortness of breath, chest pain, recurrent bronchitis and pneumonia, fatigue and weight loss may occur. When the oesophagus is involved, difficulty swallowing that starts with solid food and gradually progresses to liquids is typical.
None of these symptoms on its own means cancer; they have much more common benign causes. But if they persist, seeing a doctor without delay is vital for early diagnosis.
How Is the Diagnosis Made?
Biopsy: The Only Way to a Definitive Diagnosis
Squamous cell carcinoma can only be diagnosed by pathological examination. A tissue sample taken from the suspicious area is examined under the microscope to determine the cell type, the degree of differentiation and the features of spread. Punch, shave or excisional biopsies may be used on the skin; endoscopic biopsy in the mouth and larynx; and bronchoscopy or needle biopsy in the lung.
Some terms you will encounter in your pathology report will help you understand the process. “Well differentiated” means that the tumour cells resemble normal cells and usually behave more slowly, while “poorly differentiated” means that the cells have moved away from the normal structure and may be more aggressive. “Perineural invasion” means that the tumour is advancing along nerve sheaths, and “lymphovascular invasion” that it has reached blood or lymphatic vessels. The “depth of invasion” and the “surgical margin” also directly affect the treatment plan.
Imaging and Assessment of Spread
Ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and PET-CT may be used to determine the extent of the tumour. Small, low-risk skin lesions usually do not require additional imaging. By contrast, detailed imaging is an integral part of treatment planning for head and neck, lung and oesophageal tumours. In some cases, a sentinel lymph node biopsy may be performed to assess the lymph nodes.
Staging and Risk Groups
Staging is the foundation of the treatment plan. The internationally accepted TNM system looks at three components: T (the size and depth of the tumour), N (whether the regional lymph nodes are involved) and M (whether there are distant metastases). Combining these three pieces of information gives a stage between 0 and 4.
Broadly speaking, stage 0 is “cancer in situ”, where the cells have not yet passed from the surface into deeper layers. Stages 1 and 2 are those in which the tumour is limited and has not spread to the lymph nodes. Stage 3 means that the regional lymph nodes are involved, and stage 4 that the cancer has spread to distant organs. In the past, stage 4 was considered equivalent to hopelessness; in the era of immunotherapy, however, a growing number of patients achieve long-term disease control even at this stage.
In cutaneous squamous cell carcinoma, risk classification is used in addition to staging. Current guidelines divide tumours into three categories: low risk, high risk and very high risk. Features of the very high-risk group include a tumour diameter of more than 4 centimetres, deep perineural invasion, invasion beyond the subcutaneous fat, lymphovascular invasion and poorly differentiated histology. This classification determines which patients can be followed up after surgery alone and which will need additional treatment.
Treatment Options
The treatment plan is tailored to the individual, taking into account the location, stage and risk group of the tumour as well as the patient’s age, other illnesses and general condition. In most centres today, this decision is made jointly by a multidisciplinary board (tumour board) of oncologists, surgeons, radiation oncologists, pathologists and radiologists.
Surgical Treatment
Surgery is the main treatment, especially for early-stage squamous cell carcinoma, and can achieve a permanent cure on its own. The aim is to remove the tumour completely with a margin of healthy tissue around it. For low-risk skin tumours, excision with a 4–6 mm safety margin is usually sufficient.
In head and neck and lung tumours, surgery is more extensive, and when necessary the lymph nodes of the neck may be removed (neck dissection) or part of the lung may be taken out (lobectomy). Preserving speech, swallowing and breathing is a priority in planning these operations.
Radiotherapy
Radiotherapy aims to destroy cancer cells with high-energy radiation. It can be used for three different purposes: as the main treatment in patients who are not suitable for surgery, after surgery to eliminate microscopic cells that may have remained (adjuvant treatment), or in advanced stages to relieve symptoms. In early-stage laryngeal cancers, radiotherapy is often preferred because it can preserve the vocal cords. Thanks to modern intensity-modulated radiotherapy (IMRT), surrounding healthy tissues can be largely spared.
Chemotherapy and Chemoradiotherapy
Chemotherapy is a systemic treatment with drugs that stop cancer cells from dividing. Cisplatin, carboplatin, 5-fluorouracil and taxanes are frequently used in squamous cell carcinoma. In head and neck and oesophageal tumours, chemoradiotherapy – the combination of chemotherapy and radiotherapy – stands out as an organ-preserving approach, making it possible to avoid extensive surgery in some patients.
Immunotherapy
The most important development of recent years is the immune checkpoint inhibitors, which direct the immune system to recognise and destroy cancer cells. These drugs, which target the PD-1 and PD-L1 pathway, have changed treatment standards in many locations of squamous cell carcinoma. In advanced cutaneous squamous cell carcinoma, drugs such as cemiplimab and pembrolizumab can achieve lasting responses in patients who previously had limited options.
Immunotherapy is now used not only in advanced disease but also as additional treatment after surgery and radiotherapy in patients at high risk of recurrence. According to published trial data, cemiplimab given after surgery and radiotherapy in high-risk cutaneous squamous cell carcinoma markedly increased disease-free survival compared with placebo. This approach is not recommended for every patient, but for those who meet specific high-risk criteria, such as extracapsular spread in the lymph nodes, an advanced T stage or perineural invasion of named nerves. In lung and head and neck squamous cell carcinoma, too, immunotherapy is now established as first-line treatment, either combined with chemotherapy or on its own.
Targeted Therapies and Other Methods
Drugs such as cetuximab, which targets the EGFR receptor, are used in certain patient groups, particularly in head and neck tumours. In addition, methods such as cryotherapy (freezing), electrodesiccation and curettage, topical creams or photodynamic therapy can be chosen for superficial and very early lesions. These methods are only suitable for carefully selected, low-risk cases.
What Happens During Treatment?
The side effects of treatment depend on the method used. After surgery, pain, swelling, temporary loss of sensation and wound care during healing are to be expected. Radiotherapy can cause redness and sensitivity of the skin in the treated area and, in the head and neck region, dry mouth, changes in taste, difficulty swallowing and mouth sores. Nausea, fatigue, hair loss, low blood counts and susceptibility to infection are common with chemotherapy. The side effects of immunotherapy are different in nature: because the immune system becomes overactive, skin rashes, diarrhoea, thyroid disorders and, more rarely, inflammation of the liver or lungs can develop.
Most of these side effects are predictable and manageable. What matters is that you report every new complaint to your treatment team without delay. Early intervention is decisive in preventing serious problems, especially in patients receiving immunotherapy. Treating side effects as information that needs to be reported, rather than as “something I have to put up with”, directly improves the quality of your treatment.
Nutrition and Physical Activity
Adequate protein and calorie intake during treatment is important for tissue repair and for supporting the immune system. In head and neck and oesophageal tumours, nutrition becomes a topic of its own because of swallowing difficulties; in this case support from a dietitian and, when necessary, switching to soft or liquid foods are recommended. Regular, moderate physical activity, approved by your doctor, is one of the most effective ways to reduce cancer-related fatigue. Stopping smoking is one of the most valuable steps you can take after diagnosis, as it directly increases the success of treatment.
Psychological Support
A cancer diagnosis affects not only the body but also mental health. Disturbed sleep, anxiety, anger, worry about the future and at times a feeling of low mood are common parts of this process. Experiencing them is not a weakness. Seeking psycho-oncological support, meeting people who are going through the same process and sharing your feelings with those close to you markedly improve adherence to treatment and quality of life. Remember that your loved ones may also need support during this time.
Follow-Up After Treatment and the Risk of Recurrence
The process does not end when treatment is completed; a period of regular follow-up begins. Follow-up has two aims: to detect early whether the disease has returned and to catch the development of a new cancer. Because most recurrences appear within the first two years, check-ups are more frequent during this period, usually every three to six months. In later years the interval is gradually extended.
People who have had cutaneous squamous cell carcinoma have a higher risk of developing a new skin cancer than the general population; a full-body skin examination at least once a year is therefore recommended. Making a habit of checking your own skin in the mirror once a month also helps you notice changes early. For head and neck and lung tumours, follow-up includes periodic imaging and, when necessary, endoscopic examination in addition to the physical examination.
Prognosis: What Is the Outlook?
The prognosis varies over a very wide range depending on the location and stage of the tumour. In cutaneous squamous cell carcinoma caught at an early stage, cure rates after surgery are very high and the great majority of patients are cured completely. In HPV-related head and neck tumours, too, treatment response and long-term results are markedly better. By contrast, the course may be more difficult in patients diagnosed at an advanced stage, with distant spread or with a suppressed immune system.
It is important to remember that the statistics you come across online reflect population averages and do not describe your individual situation. These figures are often based on data from years ago and do not yet fully reflect the impact of innovations such as immunotherapy. You will get the most accurate information about your own situation from the doctor who holds your file.
Prevention and Avoiding New Cancers
Having been diagnosed does not make protective measures unnecessary; on the contrary, they become even more important. For the skin type, the basic measures are using a broad-spectrum sunscreen of at least SPF 30 every day, avoiding direct sun at midday, wearing a hat and protective clothing and staying away from sunbeds completely. In head and neck, lung and oesophageal tumours, stopping smoking both increases the success of treatment and reduces the risk of a second cancer. Limiting alcohol, HPV vaccination in the appropriate age groups and regular oral and dental check-ups also have a protective effect.
Questions You Can Ask Your Doctor
It is very common to forget the questions that come to mind during a consultation. Preparing a list beforehand and, if possible, bringing a relative who can take notes makes things easier. The following questions are a good starting framework:
- Exactly where is my tumour located, and what stage is it?
- Does my pathology report show any high-risk features?
- What treatment plan is recommended for me, and what are the alternatives?
- How long will treatment take, and how will it affect my daily life?
- Which side effects should I expect, and when should I contact you immediately?
- What will my follow-up programme look like after treatment?
- Is there a clinical trial I could take part in (especially a question for the oncologist)?
Frequently Asked Questions
Is squamous cell carcinoma fatal?
In most cases it is not. In particular, the majority of skin tumours caught at an early stage are completely cured by surgery. The course depends on the organ, stage and risk features of the tumour. It is therefore better to discuss your own medical situation rather than rely on a general answer.
Is this cancer contagious?
The cancer itself is not contagious. However, HPV, which plays a role in the development of some types of squamous cell carcinoma, can be transmitted. This does not mean that the cancer is passed on.
Is it hereditary?
Squamous cell carcinoma is generally not hereditary; it is largely associated with environmental exposures. However, genetic traits such as fair skin or certain rare hereditary syndromes can increase the risk.
Can I keep working during treatment?
Many patients can continue working, especially after surgery and during outpatient treatments. This depends on the type of treatment, the severity of side effects and the physical demands of your job. It is best to make a realistic plan together with your doctor.
Can I use herbal products and supplements?
Some herbal products and high-dose vitamin supplements can interact with chemotherapy and immunotherapy drugs, reducing the effectiveness of treatment or increasing side effects. You should tell your doctor about every product you use, including those you consider natural.
Is it right to get a second opinion?
Absolutely. Getting a second opinion is not a sign of distrust in your doctor; it is a common and respected practice in oncology. Especially before a decision on extensive surgery, getting an assessment from a different centre helps you make your decision with greater peace of mind.
Conclusion
A diagnosis of squamous cell carcinoma may be news that changes the course of your life, but it is not news that decides how it ends. This disease is one of the best understood in medicine, and one of the areas where treatment options have advanced fastest over the last decade. In cases caught early, surgery alone is often enough, and even in advanced stages long-term disease control has become possible thanks to immunotherapy.
Your strongest tool in this process is knowledge. Understanding your disease, knowing your treatment plan, recognising side effects and sticking to your follow-up programme all directly affect the outcome. Something else is equally important: knowing that you are not alone. Your treatment team, your family and people who have been through a similar process can accompany you on this path. Take each step in turn, do not skip your check-ups and do not hesitate to ask questions.
For a personal assessment of your situation, you can request an evaluation appointment; to learn about the surgeon’s training and experience, you can review the surgeon’s profile.
This content has been prepared for general information purposes and does not replace examination, diagnosis or treatment by a physician.
Assoc. Prof. Ahmet Hamdi Sakarya, MD, MSc
Specialist in Plastic, Reconstructive and Aesthetic Surgery
Assoc. Prof. Ahmet Hamdi Sakarya completed a two-year fellowship in reconstructive microsurgery and peripheral nerve surgery at Chang Gung Memorial Hospital in Taiwan, one of the world’s leading high-volume microsurgery centers. His clinical practice focuses on facial paralysis and facial reanimation, brachial plexus and other peripheral nerve injuries, functional muscle transfers, free tissue transfers and facial aesthetic surgery.




